Skip to content
Quality Assurance advanced

Peptide Drug Comparability Studies

Requirements for demonstrating comparability of peptide drug products after manufacturing changes.

By Encyclopeptide Editorial | 1 min read
comparability manufacturing-change regulatory quality CMC

Overview

Comparability studies demonstrate that changes in manufacturing do not adversely affect peptide drug product quality.

When Required

  • Manufacturing site changes
  • Equipment changes
  • Process modifications
  • Scale changes

Framework

Analytical Comparability

  • Structural characterization
  • Purity and impurity profiles
  • Biological activity

Clinical Comparability

  • PK/PD studies
  • Clinical efficacy comparison
  • Immunogenicity assessment

Chemical Identity

PropertyValue
NamePeptide Drug Comparability Studies
CategoryQuality Assurance

References

  1. Encyclopeptide Database. “Peptide Drug Comparability Studies” monograph. encyclopeptide.com.

Test Your Knowledge

Reinforce what you learned about Peptide Drug Comparability Studies with interactive quizzes on Wikipept.

Take a Quiz on Wikipept